Directory · EE
Biotechnology in Estonia
A register of firms and the professionals working at them in the Biotechnology sector based in Estonia. Browse the public index, then filter or export on Kipplo.
Companies
10 on file
Hansabiomed Life Sciences Ltd
HansaBioMed Life Sciences, founded in 2007, is the first company entirely focused on the research in the field of exosomes, extracellular vesicles (EVs) and nanoparticles. Today HansaBioMed collaborates with various international research groups, both academic and industrial, and participates in research projects aimed to implement the knowledge on the full potential of the EVs. With our expertise gathered in over 15 years of activity, we actively work not only to improve the current technologies for EV isolation and characterization but also to investigate new fields of application of the extracellular vesicles. Together with the research activities, HansaBioMed provides its customers with high quality of services and products dedicated to the exosomes and EV research. Our service portfolio includes scalable and automated purification of extracellular vesicles from conditioned media, biofluids or plant extracts, bulk or single EV characterization, biomarker assessment by mass spectrometry and RNA seq. Our catalog of products covers a broad range of purified EVs, tools for EV purification, enrichment and characterization. Our facilities are located in Tallinn (Estonia), in the Technology park Tehnopol. Since 2019, HansaBioMed is part of the Exosomics group. Exosomics is a company located in Siena (Italy), founded in 2011 by the same founders of HansaBioMed with the aim to leverage the EV potential for diagnostic purposes.
11 to 50 staff
Gearbox Biosciences
Antibiotic-free protein production in E. coli
1 to 10 staff
Biometric Dental
Biometric was founded in 2016 with the aim of developing, producing and marketing novel dental implant systems linked with virtual planning and augmented surgery. We offer high quality and user-friendly dental implant system for dentists to serve clients from all over the world for more aesthetic, long-lasting and cost-effective treatment. Combining 15 years experiences in the field of implantology, digitalization and product design we aim to become the innovation leader in the global dental implant industry.
1 to 10 staff
Bioatlas
Bioatlas is an advancing European biotechnology company providing high quality molecular biology products to researchers, distributors and OEM resellers. We started Bioatlas with the intention of establishing a portfolio of molecular biology reagents, so that people would be able to find many products they need from a single source, giving our customers the opportunity to spend less time thinking about the reagents they use and more time on their research. Our products have been developed and tested to ensure their performance in where they matter the most – your experiments. We are proud that our collaboration with our customers and partners has become long term, and these relationships are everything Bioatlas is about.
1 to 10 staff
Ada Pharma
Development of biotechnology of production of ecologically compatible standardised raw materials of medicinal plants as exemplified by Rhodiola rosea. Plants have a long selection cycle and an uncontrollable contents of biologically active substances (BAS). What complicates industrial production of medicines. Rhodiola rosea is a valuable medicinal plant. It is antioxidant, antidepressant and anticarcinogenic. It stimulates the central nervous system. We have produced micro clones of Rhodiola rosea with a high content of BAS. Later, these samples can be maintained in culture, grown up in a hydroponic hothouse or in fields, converted into a cell culture and grown up in a bioreactor. Conversion of Rhodiola rosea into culture has great prospects both for industrial production of standardised medicinal raw materials, and for preservation of this rare plant in nature.
1 to 10 staff
Pharmawise
PharmaWise is set to re-invent the medication experience through a multichannel platform that improves adherence by simplifying medication, provides user insights to Pharmaceutical, and makes it possible to analyse data for a the future personalised medication.
1 to 10 staff
Scanbalt Bioregion
ScanBalt is Northern Europe’s Leading Accelerator for Inter-regional Cooperation envisioning the region as a Global Hotspot for Health and Bio-Economy. ScanBalt creates value by promoting innovation and business, fostering inter-regional collaboration, reducing barriers, enhancing visibility and attracting resources. ScanBalt Business Club publishes company news, partner searches and job adverts. It facilitates access to business support and investors and offers discounts on events. ScanBalt HealthRegion is a flagship in the EU Baltic Sea Region Strategy. The flagship promotes Cross-Sectoral and Transnational Projects for Innovation in Health and in Life Sciences.
1 to 10 staff
Vetik
Vetik is a blue biotech startup valorizing red seaweed. Our state of the art process enables simultaneous extraction of plant biostimulants for agriculture, red pigments for cosmetics, food and textile, and pulp biomass with gelling properties for bioplastics, biofertilizers etc.
1 to 10 staff
Siriomed Oü
Estonian medical & diagnostic company with registry code: 14179675
1 to 10 staff
Zipprime Oü
ZipPrime is an R&D-based biotechnology company that has developed several novel technologies for capturing, detection and preservation of nucleic acid molecules. With a strong background in molecular biology, ZipPrime’s R&D team has been able to conceive and demonstrate a novel and far higher efficient method for molecular targeting and capturing of oligonucleotides, including rare and fragile circulating-free DNA (cfDNA) molecules, at a single molecule level. Instead of standard size selection-based nucleic acid isolation and purification methods, traditionally used in the industry, ZipPrime’s capturing technology centres around magnetic particle-based novel primer structures which can target each and every oligonucleotide molecules as a simple, elegant, accurate and low cost solution. These versatile magnetic particle-based-based structures also allow the reusable storage and enrichment of captured oligonucleotides without the need for complicated devices or protocols. An initial UK patent application for this technology was filed in 2012 and a following PCT application in 2014. ZipPrime’s intellectual property (IP) of core nucleic acid capturing, storage and enrichment technology is protected by a patent portfolio consisting of a patent family based upon the PCT application published in 2014 and entered the National/Regional Phase in key territories and ZipPrime’s first patent has been granted in February 2017.
11 to 50 staff
